Answers are grounded in this paper and cite their sources.
This research shows that hydromethanolic extracts of Mangifera indica improve grip strength and motor coordination, indicating neuroprotective benefits in ECT-induced seizures.
Electroconvulsive therapy (ECT), although clinically effective in treatment-resistant depression, is often associated with adverse neurocognitive effects, particularly impairments in learning and memory. The search for safe adjunctive therapies has drawn attention to plant-derived neuroprotectants. This study investigated the effect of hydromethanolic extracts of Mangifera indica stem bark (MSBE) and leaf (MLE) on learning and memory in ECT-induced seizure models in male Wistar rats, using beam walk and forelimb grip tests. Rats were divided into eight groups: control, ECT-only, ECT + diazepam (DZP), MSBE (300 and 600 mg/kg), and MLE (300 and 600 mg/kg). ECT markedly impaired motor coordination and grip performance, reflected in prolonged beam walk latency (Week 4: 265.00 ± 62.85 s vs. control: 53.70 ± 21.73 s, p<0.05) and reduced grip strength. Treatment with MSBE and MLE significantly attenuated these deficits, with MLE (600 mg/kg) showing the most robust effects, improving grip strength (Week 4: 28.20 ± 0.86 vs. ECT: 7.10 ± 2.07, p<0.05) and reducing beam walk latency (Week 4: 15.50 ± 6.37 s vs. ECT: 265.00 ± 62.85 s). These findings suggest that Mangifera indica extracts exert neuroprotective effects by ameliorating ECT-induced cognitive and motor deficits, potentially through antioxidant and neurotransmitter-modulatory mechanisms. The results support their therapeutic potential as adjuncts in managing neurocognitive side effects of ECT.
No takes yet. Share an insight, caveat, or question.
Otto et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: